Research Topic: Medicinal

Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids

Scientists analyzed 226 mushroom samples from about 30 psychotropic species to measure their psilocybin and related compound content. They found that the amounts of these compounds vary greatly, even within the same species, making it difficult to predict how strong a mushroom will be. The research shows that Psilocybe species generally contain the most psychoactive compounds, with some varieties containing over 15 times more psilocybin than others, highlighting safety concerns for users.

Read More »

Evaluation of Immune Modulation by β-1,3; 1,6 D-Glucan Derived from Ganoderma lucidum in Healthy Adult Volunteers, A Randomized Controlled Trial

A study tested whether a supplement made from Reishi mushroom could boost immune system function in healthy adults. Over 84 days, people taking the Reishi β-glucan supplement showed significant improvements in immune cells and antibodies compared to those taking a placebo. The supplement was safe and well-tolerated with no negative side effects, suggesting it may help strengthen the body’s natural defenses against infections.

Read More »

Potential Roles of Exogenous Proteases and Lipases as Prebiotics

This review explores how digestive enzymes like proteases and lipases work similarly to prebiotics—foods that feed beneficial bacteria in your gut. When animals consumed supplements of these enzymes, their gut bacteria became healthier, producing more beneficial compounds and showing improved intestinal health. These findings suggest that fermented foods and raw foods containing natural digestive enzymes, as well as enzyme supplements, may help promote a healthy gut microbiome.

Read More »

Psychedelics and the treatment of eating disorders: considerations for future research and practice

As researchers explore using psychedelic drugs like psilocybin to treat eating disorders, this article outlines important safety considerations and ethical guidelines needed before widespread use. While some early trials show promise, significant concerns exist including physiological risks (heart problems, nausea), psychological challenges, potential for therapist misconduct, and medication interactions. The authors recommend rigorous research designs, better inclusion of diverse populations, and careful integration of psychedelics with proven eating disorder treatments.

Read More »

Global species diversity and distribution of the psychedelic fungal genus Panaeolus

This study is a comprehensive catalog of 77 Panaeolus mushroom species worldwide, of which 20 are known to be hallucinogenic and contain psilocybin. Researchers found that these mushrooms are most commonly documented in Asia, South America, and Europe, but many regions have little to no research data. The review highlights significant gaps in our knowledge about where these species exist and which ones truly contain psychoactive compounds, information that is crucial as these fungi become legal in more countries for medical use.

Read More »

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers

This large international study of over 8,700 people found that adults who microdose psychedelics report taking small doses for health and wellness reasons. Among people with anxiety or depression, microdosers showed lower symptom levels than non-microdosers. Most microdosers used psilocybin and combined it with other substances like Lion’s Mane mushrooms or niacin, practices they refer to as stacking.

Read More »

Effects of mating-type ratio imbalance on the degeneration of Cordyceps militaris subculture and preventative measures

Cordyceps militaris is a medicinal fungus used in traditional Chinese medicine that has healing properties but degenerates quickly when repeatedly cultured in laboratories. This research found that the loss of genetic mating-type information during subculturing is the main cause of this degeneration. By separately culturing different genetic types and mixing them before production, or by using stable single genetic-type strains, farmers can maintain consistent quality fruiting bodies for harvest and medicinal use.

Read More »

Therapeutic Prospects of Undaria pinnatifida Polysaccharides: Extraction, Purification, and Functional Activity

This review examines how to extract and purify beneficial compounds called polysaccharides from wakame seaweed (Undaria pinnatifida), a popular food in East Asia. These polysaccharides have multiple health benefits including fighting oxidative damage, boosting immune function, fighting cancer cells, and promoting healthy gut bacteria. The review details various extraction methods and discusses how these compounds could be developed into functional foods and medicines.

Read More »

Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults – A Systematic Review

Psilocybin, a naturally occurring compound found in certain mushroom species, shows significant promise as a treatment for depression. Clinical studies reviewed in this research found that psilocybin-assisted therapy reduced depressive symptoms in every patient studied, with improvements lasting months after treatment. Unlike traditional antidepressants, psilocybin caused only mild temporary side effects and worked faster, suggesting it could become an important alternative treatment for depression.

Read More »

Advanced Fungal Biotechnologies in Accomplishing Sustainable Development Goals (SDGs): What Do We Know and What Comes Next?

Fungi are remarkable organisms with tremendous untapped potential for solving global challenges. They can be engineered to produce life-saving medicines like antibiotics and cholesterol-lowering drugs, create nutritious food alternatives, clean up polluted environments, and help fight climate change. As we transition to more sustainable living practices, fungi represent a natural solution that has been used for centuries but is only now being fully appreciated through modern biotechnology.

Read More »
Scroll to Top